Skip to content
Myriad Women's Health Blog

Myriad Women's Health Blog

  • Home
  • Clinical
  • Patients
  • News
  • My Twitter Profile
  • My LinkedIn Profile

Category: News

clinical Counsyl Complete Counsyl Culture Events News Patients Product Reproductive Health

We’ve delivered our one millionth screen

By CounsylJanuary 30, 2018
Continue Reading
clinical News Patients Product Reproductive Health

Counsyl Secures Approval from New York State Department of Health for Prelude™ Prenatal Screen

By CounsylJanuary 16, 2018April 4, 2018
Continue Reading
Counsyl Culture Events News

Counsyl Appoints Ann Rhoads to Board of Directors

By CounsylJanuary 4, 2018January 16, 2018
Continue Reading
clinical Counsyl Culture News

Counsyl Appoints Pamela Sedmak to Board of Directors

By CounsylDecember 14, 2017January 4, 2018
Continue Reading
Counsyl Culture Events News

Counsyl Appoints Noah Nasser as Chief Commercial Officer

By CounsylDecember 4, 2017December 14, 2017
Continue Reading
clinical News Product Reproductive Health

Foresight™ Carrier Screen enhanced with AGG analysis to refine reproductive risk for fragile X carriers

By CounsylNovember 14, 2017April 4, 2018
Continue Reading

Posts navigation

Older posts
Newer posts

Myriad Women's Health Blog

  • My Twitter Profile
  • My LinkedIn Profile

About us

Myriad Women’s Health, Inc. is a premier genetic screening and testing company. Our genetic screens provide actionable information, empowering women and their families to make critical and timely healthcare decisions, whether they’re thinking about starting a family or evaluating risk for cancer.

Formed in 2018, Myriad Women’s Health is a combination of Counsyl, Inc. and Myriad Preventive Care, a part of Myriad Genetic Laboratories, Inc.

Learn more about Myriad Women’s Health

  • myriadwomenshealth.com
  • Foresight® Carrier Screen
  • Prequel™ Prenatal Screen
  • myRisk® Hereditary Cancer Test

Subscribe to receive news from Myriad Women’s Health

Subscribe to our newsletter